Mega LifeSciences
Mega LifeSciences, also known as Mega We Care, is a prominent player in the healthcare industry, headquartered in Thailand. Founded in 1985, the company has established a strong presence across Southeast Asia, with significant operations in countries such as Myanmar, Vietnam, and Malaysia. Specialising in the development and distribution of high-quality pharmaceuticals, dietary supplements, and herbal products, Mega LifeSciences is recognised for its commitment to innovation and quality. The company’s unique formulations and extensive product range cater to diverse health needs, setting it apart in a competitive market. With a focus on enhancing health and well-being, Mega LifeSciences has achieved notable milestones, including numerous certifications and awards that underscore its market position as a trusted provider in the healthcare sector.
DitchCarbon Score
How does Mega LifeSciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Furniture Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mega LifeSciences's score of 28 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Mega LifeSciences's reported carbon emissions
In 2022, Mega LifeSciences reported total carbon emissions of approximately 627,413,270 kg CO2e. This figure includes about 633,276,080 kg CO2e from Scope 1 emissions, approximately 5,504,540 kg CO2e from Scope 2, and around 358,280 kg CO2e from Scope 3. In comparison, their emissions for 2016 were about 9,000,980 kg CO2e, with Scope 1 contributing approximately 1,808,570 kg CO2e, Scope 2 at about 6,752,890 kg CO2e, and Scope 3 at around 439,530 kg CO2e. The data indicates a significant increase in emissions from 2016 to 2022. As of 2023, the emissions data remains consistent with the previous years, showing total emissions of about 9,000,980 kg CO2e, with similar breakdowns across the scopes. Currently, Mega LifeSciences has not disclosed any specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. This lack of defined targets suggests that while the company is aware of its carbon footprint, it may not yet have formalised commitments to reduce emissions in line with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2016 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 1,808,570 | 000,000,000 | 0,000,000 |
| Scope 2 | 6,752,890 | 0,000,000 | 0,000,000 |
| Scope 3 | 439,530 | 000,000 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mega LifeSciences is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
